Idm Pharma (IDMI) Inactive 10-Q2008 Q1 Quarterly report

Content analysis

Filed: 9 May 08, 12:00am

/s/ Timothy P. Walbert

/s/ Robert J. De Vaere

Timothy P. Walbert

Robert J. De Vaere

President and Chief Executive Officer

Senior Vice President, Finance and Administration

and Chief Financial Officer

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: AICPA, Alto, analytical, API, attended, back, buy, category, CFO, clock, closure, CMC, comparison, conceived, confirmation, confirmatory, database, default, delivered, detected, devote, downgrade, East, employed, expedience, explanation, FAS, fill, filtered, forego, foregoing, forfeited, framework, FSP, good, hearing, hierarchy, identical, illiquid, incremental, inspection, instance, involuntary, Israel, JMP, labor, leaving, listing, lived, lump, lyophilized, MAK, mixed, mutual, NAV, notification, observable, oral, Palo, Postemployment, preserve, properly, publicly, putfurther, qualitative, quantitative, real, refine, relieved, restore, resume, reverted, robust, shut, shutdown, shutting, simplified, solvent, sooner, South, statutory, suggested, sum, superficial, surgery, survival, unadjusted, unobservable, usage, vacated, withholding

Removed: advice, affecting, batch, behalf, carryforward, CCG, Code, collateral, communicated, complexity, compliant, considerably, construction, contractor, conveyance, corrective, decreased, demonstrating, Dendritophage, departure, derecognition, detailed, deterioration, disclose, disclosed, disease, documentation, eligible, environment, evaluated, examination, exist, expanded, expansion, expended, fact, favor, Formalize, formation, growing, hired, implement, implementing, improve, integration, invention, irrevocable, lack, limitation, liquidation, mature, moving, negligible, NIH, NOL, occurrence, open, outsourcing, oversight, performing, POG, prepare, prescribing, prioritize, processed, promulgated, pronouncement, prosecute, reaching, reallocated, recognizing, regularly, reimbursable, reimbursed, reliable, remediate, removed, renewable, restatement, Revise, secured, shortened, skilled, summarized, supplement, taxing, threshold, title, training, typically, unpaid, unusual, unutilized, utilization, varied, viability

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

IDMI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION¹

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. § 1350), Timothy P. Walbert, the President and Chief Executive Officer of IDM Pharma, Inc. (the “Company”), and Robert J. De Vaere, the Senior Vice President, Finance and Administration and Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:

1.The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2008, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and

2.The information contained in the Periodic Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Periodic Report and results of operations of the Company for the period covered by the Periodic Report. Dated: May 9, 2008


¹		This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of IDM Pharma, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.